{"id":782025,"date":"2023-09-06T10:10:02","date_gmt":"2023-09-06T14:10:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/"},"modified":"2023-09-06T10:10:02","modified_gmt":"2023-09-06T14:10:02","slug":"60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/","title":{"rendered":"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li>Management investor presentation <a href=\"https:\/\/journey.ct.events\/view\/efc976f0-6973-4dde-8fa7-2ac855a33c43\" rel=\"nofollow noopener\" target=\"_blank\"><u>webcast<\/u><\/a> available Monday 9\/11, 7:00 AM ET<\/li>\n<li style=\"margin-bottom:8pt\">Attendees may request 1 x 1 meetings with management at <a href=\"mailto:meetings@hcwco.com\" rel=\"nofollow noopener\" target=\"_blank\">meetings@hcwco.com<\/a><\/li>\n<\/ul>\n<p align=\"left\">WASHINGTON, Sept.  06, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xEO1KboUecIuV7j-EEK7cnxMDWZc4x26GV4ypg1AWh6DOh5Rlbt2RpTCx8P4BYxc1cj76HJeU8iHsEUGEupSEeJFgM_XvPE9vUqA4_K_tvLmGoSKGITXOFXn2DCkdf6V\" rel=\"nofollow noopener\" target=\"_blank\"><u>60 Degrees Pharmaceuticals Inc.<\/u><\/a> (\u201c60P\u201d or the \u201cCompany\u201d) (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uUJrYBDh4LNw5QpH4qv5GOJvQ9zDZWGl3qioF_awWA-xZwTZzqAssEqZxIdCmSiP_MpO3Tw2ccM3MgWz6gs0_8EmadLDk_2aVESmL10F_qw=\" rel=\"nofollow noopener\" target=\"_blank\"><u>SXTP<\/u><\/a>), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that CEO Dr. Geoff Dow and CFO Ty Miller will participate in the H.C. Wainwright 25th Annual Global Investment Conference\u00a0 September 11-13, to be held in New York City.<\/p>\n<p align=\"left\">A 20-minute, pre-recorded management investor presentation will be available on demand <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dOvfjAgO7ktYS5eErpSwgC4hJmEu0QnZlY8cK4Agqcwon8m6_3ezyEisyiThvlDKET7BC4RZVSZ5Jw3ldOCNUjI3mKv7foAAx0QPTRI1ejEuegQ0zQROW48elx8ceO5_\" rel=\"nofollow noopener\" target=\"_blank\"><u>here<\/u><\/a> starting Monday September 11, 2023, 7:00 AM eastern time. Participants will be able to submit questions for management at that time through the webcast link.<\/p>\n<p>Attendees interested in 1 x 1 meetings with Dr. Dow and Mr. Miller are invited to request them through the conference\u2019s meeting scheduler at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R2S2sbT2WvXpnjXhqeq4HSdpe3H44EWrDfGKHwNjxAN33nT9QpeOkQKmNljwiVHfNlQHTslsBoI_9UklgfKHVxOUKkVkQyxAS4x4qaZDstE=\" rel=\"nofollow noopener\" target=\"_blank\"><u>meetings@hcwco.com<\/u><\/a> or by calling or emailing the investor contact below.<\/p>\n<p align=\"left\">A replay of the investor presentation will be available on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xAVsDihKyyYENb6nEym42CIbuOMdNjcg2D7Vtl50Cac0MPGp9T3xOpY0e1bz0IMWm9OxgFsH6RmSEcRP-CgV0Qgq8zw_m-idQG3FKDCnPsnxQRgtcl-DzF4H7g-0I8l8\" rel=\"nofollow noopener\" target=\"_blank\"><u>60P\u2019s\u00a0investor relations\u00a0site<\/u><\/a> for 30 days following the event.<\/p>\n<p>\n        <strong>About 60 Degrees Pharmaceuticals, Inc.<\/strong><br \/>\n        <br \/>60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases that affect the lives of millions of people. 60P achieved FDA approval of its lead product, ARAKODA\u00ae (tafenoquine), for malaria prevention, in 2018. 60P also collaborates with prominent research organizations in the U.S., Australia and Singapore. 60P\u2019s mission has been supported through in-kind funding from the United States Department of Defense and private institutional investors including Knight Therapeutics Inc., a Canadian-based pan-American specialty pharmaceutical company. 60P is headquartered in Washington D.C., with a majority-owned subsidiary in Australia. Learn more at <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WmhGTrw6C4p2CilDKa-HqD2x9hx0MuFOdPjWe2QRjJNGHJwOwBNb3IYnBf8L4aGKOtp8n7cdnVBDnuwbyb7vqNc_SprgL7-9FTqMp4JRggE=\" rel=\"nofollow noopener\" target=\"_blank\">www.60degreespharma.com<\/a><\/u>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:40%;width:40%;min-width:40%;vertical-align: top\">Media Contact:<\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;vertical-align: top\">Investor Contact:<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Sheila A. Burke<\/td>\n<td style=\"vertical-align: top\">Patrick Gaynes<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <a href=\"mailto:SheilaBurke-consultant@60degreesPharma.com\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n              <u>SheilaBurke-consultant@60degreesPharma.com<\/u><br \/>\n            <\/a>\n          <\/td>\n<td style=\"vertical-align: top\">\n            <a href=\"mailto:patrickgaynes@60degreespharma.com\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n              <u>patrickgaynes@60degreespharma.com<\/u><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">(484) 667-6330<\/td>\n<td style=\"vertical-align: top\">(310) 989-5666<\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MWQ5NDgyZTAtZjY3ZC00N2VhLWJiNWUtMTRkY2I0MWY5M2M5LTExOTM5MDc=\/tiny\/Sixty-Degrees-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Management investor presentation webcast available Monday 9\/11, 7:00 AM ET Attendees may request 1 x 1 meetings with management at meetings@hcwco.com WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) &#8212; 60 Degrees Pharmaceuticals Inc. (\u201c60P\u201d or the \u201cCompany\u201d) (Nasdaq: SXTP), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that CEO Dr. Geoff Dow and CFO Ty Miller will participate in the H.C. Wainwright 25th Annual Global Investment Conference\u00a0 September 11-13, to be held in New York City. A 20-minute, pre-recorded management investor presentation will be available on demand here starting Monday September 11, 2023, 7:00 AM eastern time. Participants will be able to submit questions for management at that time through the webcast link. Attendees interested in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-782025","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Management investor presentation webcast available Monday 9\/11, 7:00 AM ET Attendees may request 1 x 1 meetings with management at meetings@hcwco.com WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) &#8212; 60 Degrees Pharmaceuticals Inc. (\u201c60P\u201d or the \u201cCompany\u201d) (Nasdaq: SXTP), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that CEO Dr. Geoff Dow and CFO Ty Miller will participate in the H.C. Wainwright 25th Annual Global Investment Conference\u00a0 September 11-13, to be held in New York City. A 20-minute, pre-recorded management investor presentation will be available on demand here starting Monday September 11, 2023, 7:00 AM eastern time. Participants will be able to submit questions for management at that time through the webcast link. Attendees interested in &hellip; Continue reading &quot;60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-06T14:10:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference\",\"datePublished\":\"2023-09-06T14:10:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/\"},\"wordCount\":304,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/\",\"name\":\"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=\",\"datePublished\":\"2023-09-06T14:10:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference - Market Newsdesk","og_description":"Management investor presentation webcast available Monday 9\/11, 7:00 AM ET Attendees may request 1 x 1 meetings with management at meetings@hcwco.com WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) &#8212; 60 Degrees Pharmaceuticals Inc. (\u201c60P\u201d or the \u201cCompany\u201d) (Nasdaq: SXTP), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that CEO Dr. Geoff Dow and CFO Ty Miller will participate in the H.C. Wainwright 25th Annual Global Investment Conference\u00a0 September 11-13, to be held in New York City. A 20-minute, pre-recorded management investor presentation will be available on demand here starting Monday September 11, 2023, 7:00 AM eastern time. Participants will be able to submit questions for management at that time through the webcast link. Attendees interested in &hellip; Continue reading \"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-06T14:10:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference","datePublished":"2023-09-06T14:10:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/"},"wordCount":304,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/","name":"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=","datePublished":"2023-09-06T14:10:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNzIyMyM1Nzk5NDE0IzIxODIzMzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/60-degrees-pharmaceuticals-to-participate-in-h-c-wainwright-25th-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=782025"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782025\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=782025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=782025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=782025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}